Cargando…
Loss-To-Follow-Up on Multidrug Resistant Tuberculosis Treatment in Gujarat, India: The WHEN and WHO of It
BACKGROUND: Multidrug-resistant Tuberculosis (MDR-TB) is a rising global threat to public health and concerted efforts for its treatment are diluted if the outcomes are not successful, loss to follow up (LFU) being one of them. It is therefore necessary to know the proportion and the associated reas...
Autores principales: | Shringarpure, Kalpita S., Isaakidis, Petros, Sagili, Karuna D., Baxi, R. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500497/ https://www.ncbi.nlm.nih.gov/pubmed/26167891 http://dx.doi.org/10.1371/journal.pone.0132543 |
Ejemplares similares
-
“When Treatment Is More Challenging than the Disease”: A Qualitative Study of MDR-TB Patient Retention
por: Shringarpure, Kalpita S., et al.
Publicado: (2016) -
Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016–2017
por: Rathi, Priya, et al.
Publicado: (2020) -
Sputum Smear and Culture Conversion in Multidrug Resistance Tuberculosis Patients in Seven Districts of Central Gujarat, India: A Longitudinal Study
por: Patel, Sangita V., et al.
Publicado: (2018) -
Prevalence of menopausal symptoms among women in Vadodara, Central Gujarat: The urban-rural divide
por: Shringarpure, Kalpita S., et al.
Publicado: (2022) -
HIV serostatus disclosure: Experiences and perceptions of people living with HIV/AIDS and their service providers in Gujarat, India
por: Patel, Sangita V., et al.
Publicado: (2012)